Sort   by:  
 Page size 
Inhibitors targeting KRASG12C are a promising new class of oncogene-specific therapeutics for the treatment of tumors driven by KRASG12C mutations. These molecules react with the mutant cysteine residue by binding covalently to the switch-II pocket present only in the inactive-GDP state of KRASG12C,...
ORGANISM(S): Homo sapiens (Human) 
2020-03-23 | PXD013075 | Pride
Hs_4plex_protein ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe003763 | PeptideAtlas
Hs_8plex_phospho_biorep1 ETD ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe005237 | PeptideAtlas
Hs_8plex_protein_biorep1 ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe003758 | PeptideAtlas
Hs_8plex_phospho_biorep2 ETD ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe005281 | PeptideAtlas
Hs_4plex_phospho ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe003756 | PeptideAtlas
Hs_8plex_phospho_biorep2 ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe003753 | PeptideAtlas
Hs_4plex_phospho ES_iPS ETD
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe004089 | PeptideAtlas
Hs_8plex_phospho_biorep1 ES_iPS
ORGANISM(S): Homo Sapiens (human) 
2011-12-31 | PAe003798 | PeptideAtlas
Sort   by:  
 Page size